Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sinopharm Group Co Class H (HK:1099)
:1099
Holding HK:1099?
Track your performance easily
1099 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$16.02 - HK$23.65
Previous CloseN/A
Volume3.49M
Average Volume (3M)5.60M
Market Cap
HK$63.78B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)6.8
Beta0.77
Next Earnings
Mar 21, 2025EPS Estimate
1.56Last Dividend Ex-Date
Jun 17, 2024Dividend Yield4.61%
Share Statistics
EPS (TTM)3.00
Shares Outstanding1,341,810,800
10 Day Avg. Volume4,336,368
30 Day Avg. Volume5,600,262
Standard Deviation0.10
R-Squared0.32
Alpha0.00830
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.14
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$2.98Price Target Upside-85.43% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Sinopharm Group Co Class H News
PremiumCompany Announcements
Sinopharm Accord Projects Notable Profit Decline for 2024
PremiumCompany Announcements
Sinopharm Group Proposes New Director Appointments
PremiumCompany Announcements
Sinopharm Group Announces Board of Directors and Committee RolesPremiumCompany Announcements
Sinopharm Group Reports Nine-Month Financial Results
PremiumCompany Announcements
Sinopharm Group Co. Reports Mixed Financial Results
PremiumCompany Announcements
Sinopharm Group’s Asset Growth Boosts Investor Confidence
PremiumCompany Announcements
Sinopharm Subsidiary Faces Revenue and Profit Declines
PremiumCompany Announcements
Sinopharm Reports Revenue Growth with Cash Flow ChallengesOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
13.45% Mutual Funds
― Other Institutional Investors
78.01% Public Companies and
Individual Investors
1099 FAQ
What was Sinopharm Group Co Class H’s price range in the past 12 months?
Sinopharm Group Co Class H lowest stock price was HK$16.02 and its highest was HK$23.65 in the past 12 months.
What is Sinopharm Group Co Class H’s market cap?
Sinopharm Group Co Class H’s market cap is HK$63.78B.
When is Sinopharm Group Co Class H’s upcoming earnings report date?
Sinopharm Group Co Class H’s upcoming earnings report date is Mar 21, 2025 which is in 61 days.
How were Sinopharm Group Co Class H’s earnings last quarter?
Sinopharm Group Co Class H released its earnings results on Oct 28, 2024. The company reported HK$0.576 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.576.
Is Sinopharm Group Co Class H overvalued?
According to Wall Street analysts Sinopharm Group Co Class H’s price is currently Overvalued.
Does Sinopharm Group Co Class H pay dividends?
Sinopharm Group Co Class H pays a Annually dividend of HK$0.943 which represents an annual dividend yield of 4.61%. See more information on Sinopharm Group Co Class H dividends here
What is Sinopharm Group Co Class H’s EPS estimate?
Sinopharm Group Co Class H’s EPS estimate is 1.56.
How many shares outstanding does Sinopharm Group Co Class H have?
Sinopharm Group Co Class H has 1,341,810,800 shares outstanding.
What happened to Sinopharm Group Co Class H’s price movement after its last earnings report?
Sinopharm Group Co Class H reported an EPS of HK$0.576 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.602%.
Which hedge fund is a major shareholder of Sinopharm Group Co Class H?
Currently, no hedge funds are holding shares in HK:1099
---
Sinopharm Group Co Class H Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$2.98 (-85.43% Downside)
HK$2.98 (-85.43% Downside)
Blogger Sentiment
Neutral
HK:1099 Sentiment 50%
Sector Average 71%
Sector Average 71%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.21%
12-Months-Change
Fundamentals
Return on Equity
11.98%
Trailing 12-Months
Asset Growth
2.82%
Trailing 12-Months
Company Description
Sinopharm Group Co Class H
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment is distributes medical devices, financial leasing ,production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
---
1099 Stock 12 Month Forecast
Average Price Target
HK$2.98
▼(-85.43% Downside)
Technical Analysis
Sinopharm Group Co
―
Cardinal Health
―
McKesson
―
Henry Schein
―
Owens & Minor
―
HCA Healthcare
―
Novartis
―
Best Analysts Covering 1099
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+2.63%
reiterated a buy rating 5 months ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +2.63% per trade.
---